Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole Blood Transcriptome Profiling in Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease

ABSTRACT: Whole Blood Transcriptome Profiling in Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease

PROVIDER: PRJNA439192 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6868540_1.fastq.gz	Fastqsanger.gz
	SRR6868540_2.fastq.gz	Fastqsanger.gz
	SRR6868550_1.fastq.gz	Fastqsanger.gz
	SRR6868550_2.fastq.gz	Fastqsanger.gz
	SRR6868560_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 404

Similar Datasets

Molecular profiles of Systemic Juvenile Idiopathic Arthritis patients

Project description:Biomarker identification for diagnosis of systemic juvenile idiopathic arthritis (SJIA), an auto-inflammatory disease that presents with prolonged fevers.

2015-09-03 | GSE57183 | GEO

Molecular profiles of Systemic Juvenile Idiopathic Arthritis patients

Project description:Biomarker identification for diagnosis of systemic juvenile idiopathic arthritis (SJIA), an auto-inflammatory disease that presents with prolonged fevers. Disease vs. healthy control

2015-09-03 | E-GEOD-57183 | biostudies-arrayexpress

Remission in Polyarticular Juvenile Idiopathic Arthritis

Project description:Identify biomarkers to predict response to therapy in polyarticular juvenile idiopathic arthritis (JIA) using gene expression microarrays.

2009-04-13 | GSE15645 | GEO

Remission in Polyarticular Juvenile Idiopathic Arthritis

Project description:Identify biomarkers to predict response to therapy in polyarticular juvenile idiopathic arthritis (JIA) using gene expression microarrays. 42 samples from 13 controls, 14 active patients, 9 patients in clinical remission with medication (CRM), and 6 patients in clinical remission without medication (CR). All patients had polyarticular JIA.

2009-04-13 | E-GEOD-15645 | biostudies-arrayexpress

Neutrophil gene expression in systemic juvenile idiopathic arthritis

Project description:Neutrophil gene expression in systemic juvenile idiopathic arthritis

| PRJNA505535 | ENA

Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease

Project description:Comaprison of PBMCs from patients with systemic juvenile idiopathic arthritis during active and inactive disease

2007-03-31 | E-MEXP-987 | biostudies-arrayexpress

Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis

Project description:Plasma from children with juvenile idiopathic arthritis collected pre-treatment and following 3 months of treatment with methotrexate were submitted for metabolomic profiling to the NIH West Coast Metabolomics Center.

2021-05-18 | ST001815 | MetabolomicsWorkbench

Juvenile idiopathic arthritis: peripheral blood cells

Project description:Systemic-onset juvenile idiopathic arthritis (soJIA) is a rheumatic disease in childhood characterized by systemic symptoms and a relatively poor prognosis. The peripheral leukocytes are thought to play the pathological role of soJIA although the exact cause is still obscure. In this study, we aimed to clarify the cellular functional abnormality in those cells. Here, we analyzed the gene expression profile in peripheral leukocytes from 51 patients with soJIA, 6 patients with poly-articular type JIA (polyJIA) and 8 healthy children utilizing DNA microarrays. A total of 3,491 genes, including genes related to immune reponse and metabolism, were differentially expressed in patients with soJIA compared to healthy individuals. The result provides insight into the pathogenesis of soJIA. Keywords: disease state analysis Total RNA was extracted from peripheral leukocytes from 51 soJIA patients, 6 poly-articular type JIA patients, and 8 healthy children. The gene expression profile was analyzed with DNA microarrays.

2010-05-26 | E-GEOD-8361 | biostudies-arrayexpress

Remission in Juvenile Idiopathic Arthritis Achieved on Different Drug Regimens

Project description:Remission has become both the gold standard for clinical care and the end point for clinical trials for children with juvenile idiopathic arthritis (JIA). Using gene expression microarrays, we found that when remission induced by methotrexate (MTX) or MTX plus a TNF inhibitor (etanercept, Et) (MTX+Et) was compared with healthy controls, there were notable differences in gene expression patterns, demonstrating that remission is not a restoration of immunologic normalcy. Differences were detected in PBMC as well as in granulocytes. Total RNA was extracted from isolated PBMC and granulocytes from patients with polyarticular JIA and from healthy controls. Patients had achieved remission (clinical remission on medicine as defined by Wallace et al, Arthritis Rheum. 2005;52(11):3354-3562) using either MTX or MTX+Et.

2013-10-24 | E-GEOD-41831 | biostudies-arrayexpress

Juvenile idiopathic arthritis: peripheral blood cells

2008-07-01 | GSE8361 | GEO